Clinical Trial Update: Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy and safety of valemetostat in patients with selected solid tumors, including clear cell endometrial carcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Endometrial Carcinoma
• Ovarian Cancer

Drugs mentioned

• valemetostat (valemetostat)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Solid Tumor Malignancies, Clear Cell Endometrial Carcinoma | Phase 2 | Status: RECRUITING